Effect of Transcutaneous Magnetic Stimulation in Patients With Ventricular Tachycardia Storm: A Randomized Clinical Trial.

ABSTRACT:

Importance

Autonomic neuromodulation provides therapeutic benefit in ventricular tachycardia (VT) storm. Transcutaneous magnetic stimulation (TcMS) can noninvasively and nondestructively modulate a patient's nervous system activity and may reduce VT burden in patients with VT storm.

Objective

To evaluate the safety and efficacy of TcMS of the left stellate ganglion for patients with VT storm.

Design, setting, and participants

This double-blind, sham-controlled randomized clinical trial took place at a single tertiary referral center between August 2019 and July 2021. The study included 26 adult patients with 3 or more episodes of VT in 24 hours.

Interventions

Patients were randomly assigned to receive a single session of either TcMS that targeted the left stell

SUBMITTER: Markman TM 

PROVIDER: S-EPMC8851364 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature